We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$65.1B
AUM Growth
+$4.63B
Cap. Flow
+$746M
Cap. Flow %
1.15%
Top 10 Hldgs %
9.56%
Holding
3,794
New
469
Increased
1,367
Reduced
1,237
Closed
370

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$354M
2
WFC icon
Wells Fargo
WFC
+$274M
3
IBM icon
IBM
IBM
+$266M
4
QCOM icon
Qualcomm
QCOM
+$257M
5
MDLZ icon
Mondelez International
MDLZ
+$224M

Sector Composition

Rank Sector Weight
1 Technology 14.31%
2 Healthcare 10.66%
3 Consumer Discretionary 10.29%
4 Communication Services 8.78%
5 Financials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWTR
651
CALL
DELISTED
Twitter, Inc.
TWTR
$17.9M 0.03%
1,062,600
MLM icon
652
PUT
Martin Marietta Materials
MLM
$32B
$17.8M 0.03%
86,200
+25,700
+42% +$5.43M
SMPL icon
653
Simply Good Foods
SMPL
$970M
$17.6M 0.03%
+1,500,000
New +$17.8M
OLED icon
654
Universal Display
OLED
$3.89B
$17.5M 0.03%
135,787
+59,848
+79% +$7.24M
EXTR icon
655
Extreme Networks
EXTR
$2.92B
$17.5M 0.03%
1,469,946
+514,381
+54% +$5.29M
IPXL
656
DELISTED
Impax Laboratories, Inc.
IPXL
$17.4M 0.03%
857,470
+458,980
+115% +$8.77M
CNDT icon
657
Conduent
CNDT
$250M
$17.4M 0.03%
1,109,927
+172,542
+18% +$2.82M
FSLR icon
658
First Solar
FSLR
$22.4B
$17.4M 0.03%
378,561
+45,870
+14% +$2.13M
BNY
659
Bank of New York Mellon
BNY
$110B
$17.2M 0.03%
325,088
-2,236,728
-87% -$117M
PTEN icon
660
Patterson-UTI
PTEN
$4.52B
$17.2M 0.03%
+820,408
New +$15.1M
AET
661
CALL
DELISTED
Aetna Inc
AET
$17.2M 0.03%
107,900
-2,800
-3% -$437K
HII icon
662
Huntington Ingalls Industries
HII
$11.6B
$17.1M 0.03%
75,613
+12,902
+21% +$2.69M
MCHP icon
663
Microchip Technology
MCHP
$40.3B
$17.1M 0.03%
380,728
-316,450
-45% -$13.3M
BFH icon
664
PUT
Bread Financial
BFH
$4.04B
$17.1M 0.03%
96,481
+83,951
+670% +$15.6M
PLUG icon
665
Plug Power
PLUG
$3.03B
$17.1M 0.03%
6,535,228
+903,973
+16% +$2.01M
LTRPA
666
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$17.1M 0.03%
1,380,682
-416,348
-23% -$5.17M
ACCO icon
667
Acco Brands
ACCO
$387M
$17M 0.03%
1,432,185
+306,571
+27% +$3.49M
MTD icon
668
CALL
Mettler-Toledo International
MTD
$28B
$17M 0.03%
27,200
-16,600
-38% -$9.97M
NCI
669
DELISTED
Navigant Consulting, Inc.
NCI
$17M 0.03%
1,005,707
+96,014
+11% +$1.62M
MTN icon
670
PUT
Vail Resorts
MTN
$5.35B
$16.9M 0.03%
74,200
+23,700
+47% +$5.15M
VTRS icon
671
PUT
Viatris
VTRS
$19B
$16.9M 0.03%
538,600
+233,000
+76% +$7.91M
HUN icon
672
Huntsman Corp
HUN
$1.68B
$16.9M 0.03%
615,715
+540,317
+717% +$14.4M
V icon
673
CALL
Visa
V
$714B
$16.8M 0.03%
160,000
+60,000
+60% +$6.09M
BUD icon
674
PUT
AB InBev
BUD
$156B
$16.8M 0.03%
141,000
FMC icon
675
FMC
FMC
$1.41B
$16.8M 0.03%
216,992
+155,657
+254% +$11.2M

Similar funds

David Shaw's Q3 2017 Portfolio in Review

As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
  • David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
  • David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
  • David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
  • David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
  • David Shaw opened 469 new positions and closed 370 in Q3 2017.
  • David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.

Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.